• Isabelle Jaisson-Hot, Anne-Marie Schott, Christine Clippe, Christell Ganne, Touria Hajri, Bénédicte Poncet, Véronique Trillet-Lenoir, and Cyrille Colin.
• Departement d'information médicale, UMR 5823 CNRS, Hospices civils, 162, avenue Lacassagne, 69424 Lyon, France. isabelle.hot@chu-lyon.fr
• Bull Cancer. 2003 Nov 1; 90 (11): 939-45.

AbstractThe increasing costs of care make it important to identify those strategies of greatest value from both an effectiveness and cost perspective. Economic analysis is characterized by a simultaneous consideration of alternatives costs and outcomes, and can provide useful data for managerial decision making. In this paper, methods of economic evaluations in general and in cancer in particular is reviewed. In cancer treatment, preventive, curative or palliative strategies can be concerned. Economic evaluation have become increasingly important in oncology because of the proliferation of expensive new treatments. Furthermore, considering quality of life effects is particularly important in oncology, where many treatments obtain modest improvements in response or survival. Quality of life measurements are also reviewed.

11 keywords...

hide…